• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Flovent HFA (fluticasone propionate) Inhalation Aerosol

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

November 2014

Summary View

ADVERSE REACTIONS

Postmarketing Experience
  • Infections and Infestations: Esophageal candidiasis
     

 

July 2011

Summary View

6 ADVERSE REACTIONS

6.2 Postmarketing Experience
  • Gastrointestinal Disorders: Dental caries and tooth discoloration